Kidney-sparing approach for selected localized high-risk upper tract urothelial carcinoma: A pilot study combining endoscopic thulium laser ablation with perioperative disitamab vedotin and immune checkpoint inhibitors.

医学 围手术期 泌尿科 肾细胞癌 铥 肿瘤科 输尿管镜检查 内科学 上尿路 输尿管 泌尿系统 外科 激光器 光学 物理
作者
Jianjun Ye,Zeyu Chen,Xinyang Liao,Xiang Tu,Qihao Wang,Lei Zheng,Kai Chen,Qiang Wei,Yige Bao
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:43 (5_suppl): 791-791
标识
DOI:10.1200/jco.2025.43.5_suppl.791
摘要

791 Background: Radical nephroureterectomy (RNU) is the standard treatment for localized high-risk upper tract urothelial carcinoma (UTUC). However, the predominance of UTUC in elderly populations with significant comorbidities necessitates alternative treatment strategies that prioritize functional nephron preservation. This pilot study aims to assess the efficacy and safety of a comprehensive modality of kidney-sparing approach, comprising endoscopic Thulium laser ablation and perioperative systemic therapy (Disitamab vedotin [DV] and immune checkpoint inhibitors [ICIs]), in a carefully selected cohort of localized high-risk UTUC. Methods: This ongoing study, initiated in November 2021 at West China Hospital of Sichuan University, included selected patients with localized UTUC patients (cT≤2N0M0) characterized by conditions such as solitary kidney, bilateral tumors, impending/already renal insufficiency and individual refusal/ineligibility for RNU. The treatment protocol consisted of endoscopic biopsy and initial laser ablation, followed by 3-4 cycles of DV and ICIs administered every three weeks as induction therapy. Subsequently, patients underwent maximal endoscopic laser ablation. Those exhibiting efficient response received a 6-month course of DV and a 12-month course of ICIs as maintenance therapy. Co-primary endpoints were 1-yr disease-free survival (DFS) and conversion-free survival (CFS). Secondary endpoints included clinical complete response (cCR) rate, renal function benefits, and treatment safety. Results: Thirty-two patients were enrolled, with a median follow-up of 15 months. The majority of patients (26/32, 81.25%) were diagnosed with HER2-positive in biopsy-related IHC, including 3 cases of HER2 3+ and 23 cases of HER2 2+. During the follow-up, 17 local recurrences were observed in 10 patients and the 1-yr DFS rate was 68.75%. HER2 status was a significant predictive factor for local recurrence (OR, 0.15; 95% CI, 0.03, 0.91). Salvage RNU was performed in 2 patients, yielding a 1-yr CFS rate was 93.75%. The cCR rate is 78.13% (25/32). Postoperative renal function impairment was noted in 6 patients (18.75%). Mean eGFR improvements (ml/min/1.73m2) were observed with 3.15 at 1 month, 5.07 at 3 months, 2.41 at 6 months, and 3.97 at 12 months. Notably, no grade 3 or higher systemic toxicities were observed. Conclusions: Preliminary findings indicate that the combination of endoscopic Thulium laser ablation with perioperative systemic therapy (DV and ICIs) demonstrated promising efficacy and manageable safety in selected patients with localized high-risk UTUC. These results provide a solid foundation for the ongoing phase 2 trial (WUTSUP-03) and suggest a potential paradigm shift in the management of this challenging patient population.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
41完成签到,获得积分10
1秒前
刻苦的晓蕾完成签到,获得积分10
1秒前
ML完成签到,获得积分20
1秒前
笑点低的代容完成签到,获得积分10
1秒前
2秒前
619026854发布了新的文献求助10
2秒前
侯明洋发布了新的文献求助10
2秒前
猪猪半桃完成签到 ,获得积分10
2秒前
111111完成签到,获得积分20
2秒前
FashionBoy的应助被科研通管家采纳,获得10
2秒前
KK发布了新的文献求助10
2秒前
刘婷完成签到 ,获得积分10
3秒前
酷波er的应助被科研通管家采纳,获得10
3秒前
3秒前
彭于晏的应助被科研通管家采纳,获得30
3秒前
3秒前
biu发布了新的文献求助10
3秒前
搜集达人的应助被科研通管家采纳,获得10
3秒前
秋风的应助被科研通管家采纳,获得10
3秒前
畅快的惜天完成签到,获得积分10
3秒前
丘比特的应助被科研通管家采纳,获得10
3秒前
DOC_XIONG的应助被科研通管家采纳,获得10
3秒前
4秒前
传奇3的应助被科研通管家采纳,获得10
4秒前
DOC_XIONG的应助被科研通管家采纳,获得10
4秒前
4秒前
鳗鱼文涛完成签到,获得积分20
4秒前
4秒前
DW的应助被科研通管家采纳,获得10
4秒前
小蘑菇的应助被正在输入中采纳,获得10
4秒前
carbonhan发布了新的文献求助10
4秒前
4秒前
Ava的应助被科研通管家采纳,获得10
4秒前
没所谓完成签到,获得积分10
4秒前
上官若男的应助被犹豫白柏采纳,获得10
4秒前
大个的应助被科研通管家采纳,获得10
4秒前
DOC_XIONG的应助被科研通管家采纳,获得10
4秒前
秋风的应助被科研通管家采纳,获得20
4秒前
剑与芳华完成签到,获得积分10
4秒前
4秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180713
求助须知:如何正确求助?哪些是违规求助? 9570752
关于积分的说明 21814119
捐赠科研通 7776960
什么是DOI,文献DOI怎么找? 3433298
关于科研通互助平台的介绍 2557579
邀请新用户注册赠送积分活动 2479287